Ajax-Loading

Sino Biopharmaceutical Ltd - Ebitda Interest Coverage

Sino Biopharmaceutical Ltd's Fiscal Year is From January To December.

The item "Ebitda-Interest-Coverage" stands at 1.55 as of 06/30/2025, the lowest value at least since 03/31/2022, the period currently displayed.

As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Ebitda Interest Coverage" stands at 1.55. This represents a decrease of -51.56 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -54.52 percent compared to the value the year prior.
The 1 year change in percent is -54.52.
The 3 year change in percent is -87.61.

The Serie's long term average value is 12.65. It's latest available value, on 06/30/2025, is 87.71 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is +0.0%.
The Serie's change in percent from it's maximum value, on 03/31/2022, to it's latest available value, on 06/30/2025, is -95.61%.

Ebitda Interest Coverage for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Ebitda Interest Coverage905,699,262,464.00
LogoJohnson & Johnson - Ebitda Interest Coverage486,508,953,600.00
LogoAbbVie Inc - Ebitda Interest Coverage399,570,305,024.00
LogoRoche Holding AG - Ebitda Interest Coverage317,433,206,677.55
LogoAstraZeneca PLC - Ebitda Interest Coverage280,205,508,085.11